Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 113 entries
Sorted by: Best Match Show Resources per page
Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes.

BMC immunology

Sindhu S, Akhter N, Shenouda S, Wilson A, Ahmad R.
PMID: 27671862
BMC Immunol. 2016 Sep 26;17(1):33. doi: 10.1186/s12865-016-0171-y.

BACKGROUND: Fetuin-A/AHSH is a novel hepatokine that acts as a vascular calcification inhibitor and as an endogenous TLR-4 ligand. Fetuin-A may act as a positive or negative acute phase protein (APP) in disease conditions. The relationship between circulatory fetuin-A...

Cite
Sindhu S, Akhter N, Shenouda S, et al. Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes. BMC Immunol. 2016;17(1):33doi: 10.1186/s12865-016-0171-y.
Sindhu, S., Akhter, N., Shenouda, S., Wilson, A., & Ahmad, R. (2016). Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes. BMC immunology, 17(1), 33. https://doi.org/10.1186/s12865-016-0171-y
Sindhu, Sardar, et al. "Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes." BMC immunology vol. 17,1 (2016): 33. doi: https://doi.org/10.1186/s12865-016-0171-y
Sindhu S, Akhter N, Shenouda S, Wilson A, Ahmad R. Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes. BMC Immunol. 2016 Sep 26;17(1):33. doi: 10.1186/s12865-016-0171-y. PMID: 27671862; PMCID: PMC5037637.
Copy Download .nbib Format: NLM
Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran.

BMC immunology

Karami M, Ameri P, Bathaei J, Berangi Z, Pashaei T, Zahiri A, Zahraei SM, Erfani H, Ponnet K.
PMID: 28982356
BMC Immunol. 2017 Oct 05;18(1):45. doi: 10.1186/s12865-017-0228-6.

No abstract available.

Cite
Karami M, Ameri P, Bathaei J, et al. Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC Immunol. 2017;18(1):45doi: 10.1186/s12865-017-0228-6.
Karami, M., Ameri, P., Bathaei, J., Berangi, Z., Pashaei, T., Zahiri, A., Zahraei, S. M., Erfani, H., & Ponnet, K. (2017). Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC immunology, 18(1), 45. https://doi.org/10.1186/s12865-017-0228-6
Karami, Manoochehr, et al. "Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran." BMC immunology vol. 18,1 (2017): 45. doi: https://doi.org/10.1186/s12865-017-0228-6
Karami M, Ameri P, Bathaei J, Berangi Z, Pashaei T, Zahiri A, Zahraei SM, Erfani H, Ponnet K. Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC Immunol. 2017 Oct 05;18(1):45. doi: 10.1186/s12865-017-0228-6. PMID: 28982356; PMCID: PMC5628489.
Copy Download .nbib Format: NLM
Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses.

BMC immunology

Ramu S, Akbarshahi H, Mogren S, Berlin F, Cerps S, Menzel M, Hvidtfeldt M, Porsbjerg C, Uller L, Andersson CK.
PMID: 34078278
BMC Immunol. 2021 Jun 02;22(1):35. doi: 10.1186/s12865-021-00424-w.

BACKGROUND: Mast cells (MCs) are known to contribute to both acute and chronic inflammation. Bronchial epithelial cells are the first line of defence against pathogens and a deficient anti-viral response has been suggested to play a role in the...

Cite
Ramu S, Akbarshahi H, Mogren S, et al. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses. BMC Immunol. 2021;22(1):35doi: 10.1186/s12865-021-00424-w.
Ramu, S., Akbarshahi, H., Mogren, S., Berlin, F., Cerps, S., Menzel, M., Hvidtfeldt, M., Porsbjerg, C., Uller, L., & Andersson, C. K. (2021). Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses. BMC immunology, 22(1), 35. https://doi.org/10.1186/s12865-021-00424-w
Ramu, Sangeetha, et al. "Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses." BMC immunology vol. 22,1 (2021): 35. doi: https://doi.org/10.1186/s12865-021-00424-w
Ramu S, Akbarshahi H, Mogren S, Berlin F, Cerps S, Menzel M, Hvidtfeldt M, Porsbjerg C, Uller L, Andersson CK. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses. BMC Immunol. 2021 Jun 02;22(1):35. doi: 10.1186/s12865-021-00424-w. PMID: 34078278; PMCID: PMC8170739.
Copy Download .nbib Format: NLM
Dimethyl itaconate alleviates the pyroptosis of macrophages through oxidative stress.

BMC immunology

Huang SS, Guo DY, Jia BB, Cai GL, Yan J, Lu Y, Yang ZX.
PMID: 34749650
BMC Immunol. 2021 Nov 08;22(1):72. doi: 10.1186/s12865-021-00463-3.

Macrophages are involved in the pathophysiology of many diseases as critical cells of the innate immune system. Pyroptosis is a form of macrophage death that induces cytokinesis of phagocytic substances in the macrophages, thereby defending against infection. Dimethyl itaconate...

Cite
Huang SS, Guo DY, Jia BB, et al. Dimethyl itaconate alleviates the pyroptosis of macrophages through oxidative stress. BMC Immunol. 2021;22(1):72doi: 10.1186/s12865-021-00463-3.
Huang, S. S., Guo, D. Y., Jia, B. B., Cai, G. L., Yan, J., Lu, Y., & Yang, Z. X. (2021). Dimethyl itaconate alleviates the pyroptosis of macrophages through oxidative stress. BMC immunology, 22(1), 72. https://doi.org/10.1186/s12865-021-00463-3
Huang, Shan-Shan, et al. "Dimethyl itaconate alleviates the pyroptosis of macrophages through oxidative stress." BMC immunology vol. 22,1 (2021): 72. doi: https://doi.org/10.1186/s12865-021-00463-3
Huang SS, Guo DY, Jia BB, Cai GL, Yan J, Lu Y, Yang ZX. Dimethyl itaconate alleviates the pyroptosis of macrophages through oxidative stress. BMC Immunol. 2021 Nov 08;22(1):72. doi: 10.1186/s12865-021-00463-3. PMID: 34749650; PMCID: PMC8573905.
Copy Download .nbib Format: NLM
Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China.

BMC immunology

Ni J, Zhang J, Chen Y, Wang W, Liu J.
PMID: 34344301
BMC Immunol. 2021 Aug 03;22(1):50. doi: 10.1186/s12865-021-00441-9.

BACKGROUND: Good's syndrome (GS) is a rare secondary immunodeficiency disease presenting as thymoma and hypogammaglobulinemia. Due to its rarity, the diagnosis of GS is often missed.METHODS: We used the hospital information system to retrospectively screen thymoma and hypogammaglobulinemia patients...

Cite
Ni J, Zhang J, Chen Y, et al. Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China. BMC Immunol. 2021;22(1):50doi: 10.1186/s12865-021-00441-9.
Ni, J., Zhang, J., Chen, Y., Wang, W., & Liu, J. (2021). Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China. BMC immunology, 22(1), 50. https://doi.org/10.1186/s12865-021-00441-9
Ni, Jinyao, et al. "Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China." BMC immunology vol. 22,1 (2021): 50. doi: https://doi.org/10.1186/s12865-021-00441-9
Ni J, Zhang J, Chen Y, Wang W, Liu J. Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China. BMC Immunol. 2021 Aug 03;22(1):50. doi: 10.1186/s12865-021-00441-9. PMID: 34344301; PMCID: PMC8328998.
Copy Download .nbib Format: NLM
Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease.

BMC immunology

Tucker SL, Sarr D, Rada B.
PMID: 33478382
BMC Immunol. 2021 Jan 21;22(1):7. doi: 10.1186/s12865-021-00397-w.

BACKGROUND: Neutrophils are key components of the exacerbated inflammation and tissue damage in cystic fibrosis (CF) airways. Neutrophil extracellular traps (NETs) trap and kill extracellular pathogens. While NETs are abundant in the airways of CF patients and have been...

Cite
Tucker SL, Sarr D, Rada B. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease. BMC Immunol. 2021;22(1):7doi: 10.1186/s12865-021-00397-w.
Tucker, S. L., Sarr, D., & Rada, B. (2021). Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease. BMC immunology, 22(1), 7. https://doi.org/10.1186/s12865-021-00397-w
Tucker, Samantha L, et al. "Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease." BMC immunology vol. 22,1 (2021): 7. doi: https://doi.org/10.1186/s12865-021-00397-w
Tucker SL, Sarr D, Rada B. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease. BMC Immunol. 2021 Jan 21;22(1):7. doi: 10.1186/s12865-021-00397-w. PMID: 33478382; PMCID: PMC7819174.
Copy Download .nbib Format: NLM
The role of β.

BMC immunology

Altorki T, Muller W, Brass A, Cruickshank S.
PMID: 33407124
BMC Immunol. 2021 Jan 06;22(1):2. doi: 10.1186/s12865-020-00394-5.

BACKGROUND: Dendritic cells (DCs) play a key role in shaping T cell responses. To do this, DCs must be able to migrate to the site of the infection and the lymph nodes to prime T cells and initiate the...

Cite
Altorki T, Muller W, Brass A, et al. The role of β. BMC Immunol. 2021;22(1):2doi: 10.1186/s12865-020-00394-5.
Altorki, T., Muller, W., Brass, A., & Cruickshank, S. (2021). The role of β. BMC immunology, 22(1), 2. https://doi.org/10.1186/s12865-020-00394-5
Altorki, Tarfa, et al. "The role of β." BMC immunology vol. 22,1 (2021): 2. doi: https://doi.org/10.1186/s12865-020-00394-5
Altorki T, Muller W, Brass A, Cruickshank S. The role of β. BMC Immunol. 2021 Jan 06;22(1):2. doi: 10.1186/s12865-020-00394-5. PMID: 33407124; PMCID: PMC7789014.
Copy Download .nbib Format: NLM
Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma.

BMC immunology

Liu Y, Xie S, Li L, Si Y, Zhang W, Liu X, Guo L, Liu B, Lu R.
PMID: 33509081
BMC Immunol. 2021 Jan 28;22(1):10. doi: 10.1186/s12865-021-00399-8.

BACKGROUND: This study investigates the effect of autologous bone marrow transfusion (BMT) on the reconstruction of both bone marrow and the immune system in patients with AIDS-related lymphoma (ARL).METHODS: A total of 32 patients with ARL participated in this...

Cite
Liu Y, Xie S, Li L, et al. Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma. BMC Immunol. 2021;22(1):10doi: 10.1186/s12865-021-00399-8.
Liu, Y., Xie, S., Li, L., Si, Y., Zhang, W., Liu, X., Guo, L., Liu, B., & Lu, R. (2021). Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma. BMC immunology, 22(1), 10. https://doi.org/10.1186/s12865-021-00399-8
Liu, Yixuan, et al. "Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma." BMC immunology vol. 22,1 (2021): 10. doi: https://doi.org/10.1186/s12865-021-00399-8
Liu Y, Xie S, Li L, Si Y, Zhang W, Liu X, Guo L, Liu B, Lu R. Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma. BMC Immunol. 2021 Jan 28;22(1):10. doi: 10.1186/s12865-021-00399-8. PMID: 33509081; PMCID: PMC7845098.
Copy Download .nbib Format: NLM
Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach.

BMC immunology

Lubyayi L, Mawa PA, Cose S, Elliott AM, Levin J, Webb EL.
PMID: 34535083
BMC Immunol. 2021 Sep 17;22(1):63. doi: 10.1186/s12865-021-00453-5.

BACKGROUND: Immuno-epidemiologists are often faced with multivariate outcomes, measured repeatedly over time. Such data are characterised by complex inter- and intra-outcome relationships which must be accounted for during analysis. Scientific questions of interest might include determining the effect of...

Cite
Lubyayi L, Mawa PA, Cose S, et al. Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach. BMC Immunol. 2021;22(1):63doi: 10.1186/s12865-021-00453-5.
Lubyayi, L., Mawa, P. A., Cose, S., Elliott, A. M., Levin, J., & Webb, E. L. (2021). Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach. BMC immunology, 22(1), 63. https://doi.org/10.1186/s12865-021-00453-5
Lubyayi, Lawrence, et al. "Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach." BMC immunology vol. 22,1 (2021): 63. doi: https://doi.org/10.1186/s12865-021-00453-5
Lubyayi L, Mawa PA, Cose S, Elliott AM, Levin J, Webb EL. Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach. BMC Immunol. 2021 Sep 17;22(1):63. doi: 10.1186/s12865-021-00453-5. PMID: 34535083; PMCID: PMC8449434.
Copy Download .nbib Format: NLM
Reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China.

BMC immunology

Wei B, Guo Y, Zhang L, Zhong H, Miao Q, Yan L, Bai Y, Feng W, Liu W, Niu Q, Li Y.
PMID: 34930155
BMC Immunol. 2021 Dec 20;22(1):80. doi: 10.1186/s12865-021-00474-0.

BACKGROUND: Appropriate reference ranges of T lymphocyte subsets are essential for immune status evaluation of patients with immunological diseases. We aim to establish the age- and sex-related reference intervals of T lymphocyte subsets by single-platform for the southwest China...

Cite
Wei B, Guo Y, Zhang L, et al. Reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China. BMC Immunol. 2021;22(1):80doi: 10.1186/s12865-021-00474-0.
Wei, B., Guo, Y., Zhang, L., Zhong, H., Miao, Q., Yan, L., Bai, Y., Feng, W., Liu, W., Niu, Q., & Li, Y. (2021). Reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China. BMC immunology, 22(1), 80. https://doi.org/10.1186/s12865-021-00474-0
Wei, Bin, et al. "Reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China." BMC immunology vol. 22,1 (2021): 80. doi: https://doi.org/10.1186/s12865-021-00474-0
Wei B, Guo Y, Zhang L, Zhong H, Miao Q, Yan L, Bai Y, Feng W, Liu W, Niu Q, Li Y. Reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China. BMC Immunol. 2021 Dec 20;22(1):80. doi: 10.1186/s12865-021-00474-0. PMID: 34930155.
Copy Download .nbib Format: NLM
A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate.

BMC immunology

Jeon JH, Kim YH, Kim KA, Kim YR, Woo SJ, Choi YJ, Rhie GE.
PMID: 33743606
BMC Immunol. 2021 Mar 21;22(1):20. doi: 10.1186/s12865-021-00414-y.

BACKGROUND: Bacillus ancthracis causes cutaneous, pulmonary, or gastrointestinal forms of anthrax. B. anthracis is a pathogenic bacterium that is potentially to be used in bioterrorism because it can be produced in the form of spores. Currently, protective antigen (PA)-based...

Cite
Jeon JH, Kim YH, Kim KA, et al. A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate. BMC Immunol. 2021;22(1):20doi: 10.1186/s12865-021-00414-y.
Jeon, J. H., Kim, Y. H., Kim, K. A., Kim, Y. R., Woo, S. J., Choi, Y. J., & Rhie, G. E. (2021). A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate. BMC immunology, 22(1), 20. https://doi.org/10.1186/s12865-021-00414-y
Jeon, Jun Ho, et al. "A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate." BMC immunology vol. 22,1 (2021): 20. doi: https://doi.org/10.1186/s12865-021-00414-y
Jeon JH, Kim YH, Kim KA, Kim YR, Woo SJ, Choi YJ, Rhie GE. A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate. BMC Immunol. 2021 Mar 21;22(1):20. doi: 10.1186/s12865-021-00414-y. PMID: 33743606; PMCID: PMC7981958.
Copy Download .nbib Format: NLM
Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease.

BMC immunology

Srinivasan A, Bajana S, Pankow A, Yuen C, Shah RK, Sun XH.
PMID: 34256699
BMC Immunol. 2021 Jul 13;22(1):46. doi: 10.1186/s12865-021-00432-w.

BACKGROUND: Acute graft-versus-host disease (aGVHD) is one of the most common causes of morbidity for patients undergoing allogeneic stem cell transplantation. There is preliminary evidence that activated Group 2 innate lymphoid cells (ILC2s) from wild type (WT) mice reduces...

Cite
Srinivasan A, Bajana S, Pankow A, et al. Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease. BMC Immunol. 2021;22(1):46doi: 10.1186/s12865-021-00432-w.
Srinivasan, A., Bajana, S., Pankow, A., Yuen, C., Shah, R. K., & Sun, X. H. (2021). Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease. BMC immunology, 22(1), 46. https://doi.org/10.1186/s12865-021-00432-w
Srinivasan, Anand, et al. "Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease." BMC immunology vol. 22,1 (2021): 46. doi: https://doi.org/10.1186/s12865-021-00432-w
Srinivasan A, Bajana S, Pankow A, Yuen C, Shah RK, Sun XH. Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease. BMC Immunol. 2021 Jul 13;22(1):46. doi: 10.1186/s12865-021-00432-w. PMID: 34256699; PMCID: PMC8278660.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 113 entries